Missing a chance to prevent:disparities in completion of genetic evaluation in high-risk patients with endometrial cancer
- Author:
Sharonne HOLTZMAN
1
;
Jessica VELASQUEZ
;
Mona SALEH
;
Samantha COHEN
;
Monica PRASAD-HAYES
;
Kristen ZELIGS
;
Stephanie V. BLANK
Author Information
- Publication Type:Original Article
- From:Journal of Gynecologic Oncology 2025;36(2):e94-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objective:The primary goal of this study is to examine disparities in high-risk endometrial cancer (EC) patients in relation to rates of genetic referrals (GR), testing (GT), and counseling (GC).
Methods:This is a retrospective analysis of patients with newly diagnosed EC between January 1, 2014 and September 1, 2020 at a single institution. Patients were defined as highrisk EC patients when they were 1) diagnosed at 50 years or younger, 2) had a positive family history for cancer or 3) had evidence of loss of mismatch repair protein expression on tumor immunohistochemistry. Rates of GR, GT and GC were analyzed based on race, ethnicity, primary language and insurance status.
Results:During the study period, 674 patients were diagnosed with EC and 249 (36.9%) were considered high-risk EC patients. Among high-risk patients, 128 (51.2%) were referred to GT and GC. Of those referred, 103 (80.5%) underwent GT and 85 (66.4%) completed GC. Out of all high-risk patients, 20 (18.4%) were positive for LS on GT and 29 (28.2%) had VUS results.In multivariate analysis, the odds of GT and GC referral were lower among patients who identified as Hispanic (OR=0.40; 95% CI=0.19–0.87; p=0.020). Patients who identified as black were less likely to receive GC when compared to patients of other races (p=0.030).
Conclusion:It is our hope that through this data we will increase awareness around existing disparities in genetic evaluation for patients with EC and ultimately create strategies to improve equitable access to care for all patients.
